Zhangzhou Pientzehuang Pharmaceutical Co Ltd Capital Reinvestment Ratio
Zhangzhou Pientzehuang Pharmaceutical Co Ltd capital reinvestment ratio. Zhangzhou Pientzehuang Pharmaceutical Co Ltd (600436) has a Capital Reinvestment Ratio of 0.48x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥117.38 Million) in capital expenditures (CN¥56.87 Million). See Zhangzhou Pientzehuang Pharmaceutical Co (600436) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Zhangzhou Pientzehuang Pharmaceutical Co Ltd (2001–2025)
Capital reinvestment ratio of Zhangzhou Pientzehuang Pharmaceutical Co Ltd from 2001 to 2025. This chart tracks Zhangzhou Pientzehuang Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 24 annual periods. See Zhangzhou Pientzehuang Pharmaceutical Co leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
Zhangzhou Pientzehuang Pharmaceutical Co Ltd Capital Reinvestment Ratio by Year (2001–2025)
Zhangzhou Pientzehuang Pharmaceutical Co Ltd capital reinvestment ratio by year from 2001 to 2025. For the full cash flow conversion analysis, see 600436 cash generation efficiency.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 4.41x | CN¥77.03 Million | CN¥339.80 Million | ▲ +442.5% |
| 2024 | 0.81x | CN¥1.31 Billion | CN¥1.07 Billion | ▲ +1164.8% |
| 2023 | 0.06x | CN¥2.21 Billion | CN¥141.87 Million | ▲ +152.0% |
| 2022 | 0.03x | CN¥6.87 Billion | CN¥175.37 Million | ▼ -87.2% |
| 2021 | 0.20x | CN¥462.27 Million | CN¥92.17 Million | ▼ -30.2% |
| 2020 | 0.29x | CN¥1.47 Billion | CN¥419.01 Million | ▲ +135.6% |
| 2018 | 0.12x | CN¥612.31 Million | CN¥74.24 Million | ▲ +58.2% |
| 2017 | 0.08x | CN¥676.93 Million | CN¥51.87 Million | ▼ -66.8% |
| 2016 | 0.23x | CN¥394.54 Million | CN¥90.97 Million | ▼ -10.7% |
| 2015 | 0.26x | CN¥305.51 Million | CN¥78.86 Million | ▲ +164.0% |
| 2014 | 0.10x | CN¥264.50 Million | CN¥25.87 Million | ▼ -81.7% |
| 2013 | 0.53x | CN¥274.34 Million | CN¥146.54 Million | ▼ -44.1% |
| 2012 | 0.96x | CN¥162.40 Million | CN¥155.22 Million | ▲ +526.1% |
| 2011 | 0.15x | CN¥232.95 Million | CN¥35.56 Million | ▼ -19.4% |
| 2010 | 0.19x | CN¥205.41 Million | CN¥38.90 Million | ▼ -17.3% |
| 2009 | 0.23x | CN¥129.52 Million | CN¥29.67 Million | ▼ -95.1% |
| 2008 | 4.65x | CN¥12.57 Million | CN¥58.50 Million | ▲ +162.4% |
| 2007 | 1.77x | CN¥60.04 Million | CN¥106.47 Million | ▲ +932.2% |
| 2006 | 0.17x | CN¥50.70 Million | CN¥8.71 Million | ▼ -65.6% |
| 2005 | 0.50x | CN¥69.06 Million | CN¥34.54 Million | ▲ +358.9% |
| 2004 | 0.11x | CN¥98.67 Million | CN¥10.75 Million | ▼ -77.3% |
| 2003 | 0.48x | CN¥32.36 Million | CN¥15.56 Million | ▲ +419.2% |
| 2002 | 0.09x | CN¥105.45 Million | CN¥9.77 Million | ▼ -47.6% |
| 2001 | 0.18x | CN¥65.84 Million | CN¥11.64 Million | — |